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Abstract: 
 
The coexistence of lung cancer with another endobronchial malignant lesion is well known, 
although lung cancer with endobronchial hamartoma is infrequent, and requires accurate 
oncologic evaluation of the endobronchial lesion prior to potential surgical treatment of the lung 
cancer.  These entities can lead to significant diagnostic confusion when encountered together 
and lead to inappropriate patient staging and treatment. We describe a patient with an 
undiagnosed endobronchial mass and a biopsy-proven lung cancer.  She presented at another 
institution and was considered unresectable.  She was then successfully managed by a staged 
approach using initial complete bronchoscopic resection of the endobronchial mass, which was 
found to be benign but completely obstructing the airway, and subsequent right upper lobectomy 
and mediastinal lymphadenectomy.  The right upper lobe mass was squamous carcinoma and 
was ultimately stage 1A disease. 
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Introduction: 
 
The survival of lung cancer patients as a group is still poor when compared to breast cancer, 
prostate cancer or colon cancer patients.  Screening for lung cancer with low-dose computer 
tomography (CT) has improved survival by detection of early-stage cases.  However, 
identification of additional abnormalities on CT scan can increase the complexity of preoperative 
planning.  There will be a new cohort of patients who are found to have early stage lung cancer 
but yet have other pathology noted on the CT scan which require additional diagnostic tests and 
staging to ensure that patients are treated appropriately by surgical resection. 
 
Bronchoscopy is an important tool in providing airway clearance by the surgeon prior to 
resection in lung cancer patients, since endobronchial abnormalities may be missed on screening 
CT studies. 
 
Identification of an endobronchial mass in conjunction with a suspicious but otherwise resectable 
lung mass requires histopathologic diagnosis of the endobronchial lesion to ensure an 
oncologically adequate resection of the lung lesion.  The endobronchial lesion may also cause 
postoperative complications due to bleeding or distal airway obstruction.  Preoperative planning 
must adequately address these aspects of this association of endobronchial and parenchymal 
“mass lesions", since they may or may not be related to each other.  Other cases of diagnostic 
dilemma have been described with other malignant lesions where the simultaneous occurrence of 
pulmonary hamartomas has necessitated thoracotomy and resection to obtain a final diagnosis.1 
In this case the bronchoscopy showed a lesion that was assessed, biopsied, found to be 
removable at the time of bronchoscopy, and resected using a snare technique, without the need 
for open surgical removal. This has been previously described in a case report as an isolated 
procedure to resect a similar giant endobronchial hamartoma causing airway obstruction by a 
well reputed group.2 We describe a case of benign endobronchial hamartoma in conjunction with 
lung cancer which initially led to diagnostic confusion, but was ultimately resolved in two 
separate procedures to a satisfactory conclusion. 
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Case report:  
 
A 63 year old Caucasian female with a reformed smoking history presented with an occasional 
dry cough for several months. Chest CT scan showed some minor right lower lobe atelectasis in 
addition to a right upper lobe pulmonary mass 1.8 x 1.4 cm, located medially in the upper lobe 
adjacent to the superior vena cava but with no radiographic evidence of mediastinal invasion. 
(Figure 1)  Bronchoscopy by her pulmonologist noted a “polyp” in the bronchus intermedius.  
No attempt was made to biopsy the endobronchial lesion.  The RUL lung lesion could not be 
accessed for biopsy but brushings, washings and lavage cytology were all non diagnostic.  CT 
directed needle biopsy of the parenchymal lesion showed squamous carcinoma of the right upper 
lobe.  Pet scan showed hypermetabolism in the right upper lobe mass and no evidence of 
mediastinal, endobronchial or distant hypermetabolism.   
 
Figure 1:   
Chest CT scan showing 
right upper lobe mass 
confirmed on biopsy to be 
non small cell carcinoma. 
Routine CT scanning was 
used and there was no 
evidence of endobronchial 
disease. 
 
 
 
 
 
 
 
 
 
 
Right chest exploration was planned at another hospital; bronchoscopy following induction of 
general anesthesia visualized a hypervascular appearing endobronchial lesion completely 
obstructing the bronchus intermedius.  Only a superficial biopsy was done because of concern 
regarding bleeding from the lesion; biopsy was non diagnostic.  The operating surgeon consulted 
a pulmonologist to the operating room to also evaluate the bronchoscopic appearance of the 
lesion, and the planned thoracotomy and lobectomy were not attempted because of concerns 
regarding possible post operative obstruction in the bronchus intermedius due to the 
endobronchial lesion.  The patient was then re-referred to our facility (MHC). 
 
The patient continued to have a non productive cough, but denied fever, hemoptysis or chest 
discomfort. She had a 20 pack- year smoking history but had stopped smoking 20 years ago.  
Family history was positive for both lung cancer and breast cancer, and also for coronary artery 
disease. The patient had no personal history of COPD, cardiac disease, or visceral cancer.  Past 
medical history included difficulty sleeping, restless leg syndrome and chronic low back pain for 
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which she received treatment at a pain clinic. She had occupational exposure to paint and also 
quarry work, but no asbestos exposure.  Physical examination showed weight of 137 pounds and 
mild wheezing on the right.  FEV1.0 was 2.17 and FVC was 2.61. Room air pulse oximetry 
declined to 95% following a six minute walk.  The patient had never used oxygen at home and 
was able to climb a flight of stairs with relative ease. Preoperative hematocrit and blood 
chemistry values were normal. 
 
At outpatient bronchoscopy the lesion in the bronchus intermedius was visualized (Figure 2A). It 
was noted that the lesion could be moved inside the airway and was attached to the airway by a 
stalk. After injection with epinephrine, the lesion was removed using hotwire cautery followed 
by argon plasma coagulation to the bed of the lesion (Figure 2B). There were no complications; 
intraoperative frozen section showed hamartoma.   Final pathology showed no evidence of 
malignancy and confirmed the frozen section diagnosis of endobronchial hamartoma.  After 
review of the now benign diagnosis of the endobronchial lesion and the clearance of her airway, 
the patient was readmitted to hospital one week later where she underwent right upper lobectomy 
and mediastinal lymph node dissection. She was discharged after 5 days without complicatons. 
Pathology showed a stage 1A squamous carcinoma in the resected right upper lobe, with no 
lymph node involvement.  Oncology consultants recommended no further treatment.  The patient 
was discharged home in five days with an uncomplicated postoperative course, and has returned 
to work.  She remains well with an unremarkable postoperative CXR. 
 
   
Figure 2A:  
Bronchoscopic view of the 
endobronchial lesion encountered 
during the bronchoscopic procedure 
performed at North Knoxville 
Medical Center. The Olympus 
bronchoscope is able to be passed 
around the lesion which is attached 
to the bronchial wall by a stalk. 
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Figure 2B:   
Bronchoscopic view of the airway 
after resection of the endobronchial 
hamartoma, including cauterization 
of the base. Olympus 
bronchoscope is passed into the 
right main stem bronchus. The 
airway is now free from 
obstruction after removal of the 
hamartoma. There is no evidence 
of inflammation in surrounding 
airway or distal to the lesion 
 
 
 
 
 
 
Discussion:  
 
Endobronchial hamartomas are uncommon tumors, comprising approximately 2% of all 
pulmonary hamartomas.3 As an isolated lesion, an endobronchial hamartoma is most often 
diagnosed by bronchoscopy during an evaluation of either recurrent respiratory infections, 
caused by airway obstruction by the hamartoma, or hemoptysis.  In a series of 47 endobronchial 
hamartomas diagnosed by bronchial biopsy over a 23 year period at a tertiary level institution, 
only 7 were an incidental endoscopic finding during evaluation of a lung malignancy.4 Our 
patient had minimal symptoms despite the presence of a large lesion producing complete 
obstruction of the bronchus intermedius. On retrospective review of the CT scan there was 
nothing to suggest the presence of an endobronchial lesion; this reassures our knowledge that 
both fibreoptic bronchoscopy and high resolution scans are complementary in preoperative 
patient evaluation.  
 
Endobronchial hamartomas have been removed using both rigid and flexible bronchoscopy, 
using laser resection, or resection with electrocautery snare and argon plasma coagulation of the 
base of the lesion,5 as was done in this case, or by an intrathoracic approach, using either 
bronchotomy and bronchoplasty6 or lobectomy or bilobectomy.4,7  With a known parenchymal 
malignancy requiring resection, an endobronchial mass requires diagnosis and then either 
preoperative or intraoperative removal to prevent post obstructive complications, and to ensure 
oncologic adequacy of the lung resection by verifying the benign nature of the endobronchial 
lesion.  In this case, attempting to remove the hamartoma at the time of upper lobectomy would 
have necessitated at least a sleeve resection with sacrifice of the uninvolved middle lobe.  At the 
time of bronchoscopy, we were unaware of the nature of the endobronchial lesion, but were 
pleasantly surprised by its non malignant nature and relative ease of removal.  Thus preoperative 
management by bronchoscopy confirmed the benign nature of the lesion and reduced the risk of 
postobstructive obstruction of the remaining right lung following upper lobectomy. We will 
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continue to follow the patient both clinically and also bronchoscopically since recurrences of 
endobronchial hamartomas have been described. 
 
Preliminary management of an endobronchial mass incidentally discovered during evaluation for 
a pulmonary parenchymal malignancy, using bronchoscopic techniques, prior to planned lung 
resection, will reduce the risk of postoperative obstructive symptoms, bleeding from the mass, or 
oncologic inadequacy of the resection by ensuring that the endobronchial lesion itself is benign.  
We believe that as CT screening is more widely adopted more instances of associated pulmonary 
lesions will become apparent.  In this case however it was bronchoscopy that identified a lesion 
not noted on CT scan.  The two techniques are considered complimentary to each other.  Both 
bronchoscopy and CT scan findings will enhance the diagnostic challenges of identifying such 
lesions as benign or malignant.  This is in a time when rapidly evolving technology has made it 
important to be as discerning as possible about co-existing abnormalities to save unneccessary 
procedures, and also to ensure that patients have appropriate procedures to enhance diagnostic 
accuracy.  This may contribute to the progressively improving survival in lung cancer patients. 
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